SEOM-GEICO clinical guideline on epithelial ovarian cancer (2023)

被引：2

作者：

Perez-Fidalgo, Jose Alejandro ^{[1
]}

Galvez-Montosa, Fernando ^{[2
]}

Guerra, Eva Maria ^{[3
]}

Madariaga, Ainhoa ^{[4
]}

Manzano, Aranzazu ^{[5
]}

Martin-Lorente, Cristina ^{[6
]}

Rubio-Perez, Maria Jesus ^{[7
]}

Alarcon, Jesus ^{[8
]}

Barretina-Ginesta, Maria Pilar ^{[9
]}

Gaba, Lydia ^{[10
]}

机构：

[1] Univ Valencia, Hosp Clin Univ, Biomed Res Inst INCL, Valencia, Spain

[2] Hosp Univ Jaen, Jaen, Spain

[3] Hosp Univ Ramon y Cajal, Madrid, Spain

[4] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain

[5] Hosp Clin San Carlos, Madrid, Spain

[6] Hosp Santa Creu & Sant Pau, Radiol, Barcelona, Spain

[7] Univ Cordoba UCO, Hosp Univ Reina Sofia, Cordoba, Spain

[8] Hosp Univ Son Espases, Mallorca, Spain

[9] Univ Girona, Inst Invest Biomed Girona IDIBGI, Med Sci Dept, Inst Catala Oncol,Med Oncol Dept,Precis Oncol Grp, Girona, Spain

[10] Univ Barcelona, Hosp Clin, Translat Genom & Targeted Therapies Solid Tumors, Med Oncol Dept,IDIBAPS,Dept Med, Barcelona, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期

关键词：

Ovarian cancer; Guideline; Diagnosis; Treatment; PEGYLATED LIPOSOMAL DOXORUBICIN; OPEN-LABEL; MAINTENANCE THERAPY; DOUBLE-BLIND; SECONDARY CYTOREDUCTION; PLUS BEVACIZUMAB; RECURRENT; CHEMOTHERAPY; MULTICENTER; OLAPARIB;

D O I：

10.1007/s12094-024-03531-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the incorporation of new strategies to the therapeutic armamentarium has completely changed the outcomes of epithelial ovarian cancer (EOC). The identification of new predictive and prognostic biomarkers has also enabled the selection of those patients more likely to respond to targeted agents. Nevertheless, EOC is still a highly lethal disease and resistance to many of these new agents is common. The objective of this guideline is to summarize the most relevant strategies to manage EOC, to help the clinician throughout the challenging diagnostic and therapeutic processes and to provide evidence-based recommendations.

引用

页码：2758 / 2770

页数：13

共 50 条

[31] SEOM clinical guideline for treatment of kidney cancer (2019)
M. Lázaro
B. P. Valderrama
C. Suárez
G. de-Velasco
C. Beato
I. Chirivella
A. González-del-Alba
N. Laínez
M. J. Méndez-Vidal
J. A. Arranz
Clinical and Translational Oncology, 2020, 22 : 256 - 269
[32] SEOM Clinical Guideline of localized rectal cancer (2016)
Gonzalez-Flores, E.
Losa, F.
Pericay, C.
Polo, E.
Rosello, S.
Safont, M. J.
Vera, R.
Aparicio, J.
Cano, M. T.
Fernandez-Martos, C.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1163 - 1171
[33] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
R. Vera
E. Dotor
J. Feliu
E. González
B. Laquente
T. Macarulla
E. Martínez
J. Maurel
M. Salgado
J. L. Manzano
Clinical and Translational Oncology, 2016, 18 : 1172 - 1178
[34] SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
Munoz Martin, A. J.
Gallardo Diaz, E.
Garcia Escobar, I
Macias Montero, R.
Martinez-Marin, V
Pachon Olmos, V
Perez Segura, P.
Quintanar Verduguez, T.
Salgado Fernandez, M.
CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 171 - 186
[35] SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
A. J. Muñoz Martín
E. Gallardo Díaz
I. García Escobar
R. Macías Montero
V. Martínez-Marín
V. Pachón Olmos
P. Pérez Segura
T. Quintanar Verdúguez
M. Salgado Fernández
Clinical and Translational Oncology, 2020, 22 : 171 - 186
[36] Correction to: SEOM clinical guideline for treatment of kidney cancer (2017)
E. Gallardo
M. J. Méndez-Vidal
J. L. Pérez-Gracia
J. M. Sepúlveda-Sánchez
M. Campayo
I. Chirivella-González
X. García-del-Muro
A. González-del-Alba
E. Grande
C. Suárez
Clinical and Translational Oncology, 2019, 21 : 692 - 693
[37] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Rueda Dominguez, Antonio
Cirauqui, Beatriz
Garcia Castano, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernandez, Beatriz
Iglesias Rey, Leticia
Rubio-Casadevall, Jordi
Arrazubi, Virginia
Mesia, Ricard
CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04): : 670 - 680
[38] SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
Antonio Rueda Domínguez
Beatriz Cirauqui
Almudena García Castaño
Ruth Alvarez Cabellos
Alberto Carral Maseda
Beatriz Castelo Fernández
Leticia Iglesias Rey
Jordi Rubió-Casadevall
Virginia Arrazubi
Ricard Mesía
Clinical and Translational Oncology, 2022, 24 : 670 - 680
[39] SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
María José Méndez-Vidal
Martin Lázaro Quintela
Nuria Lainez-Milagro
Begoña Perez-Valderrama
Cristina Suárez Rodriguez
José Ángel Arranz Arija
Ignacio Peláez Fernández
Enrique Gallardo Díaz
Julio Lambea Sorrosal
Aránzazu González-del-Alba
Clinical and Translational Oncology, 2023, 25 : 2732 - 2748
[40] SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
M. Martin-Richard
R. Díaz Beveridge
V. Arrazubi
M. Alsina
M. Galan Guzmán
A. B. Custodio
C. Gómez
F. L. Muñoz
R. Pazo
F. Rivera
Clinical and Translational Oncology, 2016, 18 : 1179 - 1186

← 1 2 3 4 5 →